company background image
HARP logo

Harpoon Therapeutics NasdaqCM:HARP Stok Raporu

Son Fiyat

US$23.01

Piyasa Değeri

US$492.3m

7D

0.2%

1Y

243.4%

Güncellenmiş

11 Mar, 2024

Veri

Şirket Finansalları +

Harpoon Therapeutics, Inc.

NasdaqCM:HARP Stok Raporu

Piyasa değeri: US$492.3m

HARP Stoklara Genel Bakış

Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases in the United States.

Harpoon Therapeutics, Inc. Rakipler

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Harpoon Therapeutics
Tarihsel hisse senedi fiyatları
Güncel Hisse FiyatıUS$23.01
52 Haftanın En Yüksek SeviyesiUS$23.21
52 Haftanın En Düşük SeviyesiUS$3.11
Beta2.1
11 Aylık Değişim2.49%
3 Aylık Değişim162.97%
1 Yıllık Değişim243.43%
33 Yıllık Değişim-88.71%
5 Yıllık Değişim-81.26%
Halka arzdan bu yana değişim-82.96%

Son Haberler & Güncellemeler

Improved Revenues Required Before Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stock's 97% Jump Looks Justified

Jan 30
Improved Revenues Required Before Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stock's 97% Jump Looks Justified

Recent updates

Improved Revenues Required Before Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stock's 97% Jump Looks Justified

Jan 30
Improved Revenues Required Before Harpoon Therapeutics, Inc. (NASDAQ:HARP) Stock's 97% Jump Looks Justified

Harpoon Therapeutics, Inc. (NASDAQ:HARP) Looks Inexpensive After Falling 55% But Perhaps Not Attractive Enough

Oct 01
Harpoon Therapeutics, Inc. (NASDAQ:HARP) Looks Inexpensive After Falling 55% But Perhaps Not Attractive Enough

Analysts Just Made A Notable Upgrade To Their Harpoon Therapeutics, Inc. (NASDAQ:HARP) Forecasts

Aug 14
Analysts Just Made A Notable Upgrade To Their Harpoon Therapeutics, Inc. (NASDAQ:HARP) Forecasts

Forecast: Analysts Think Harpoon Therapeutics, Inc.'s (NASDAQ:HARP) Business Prospects Have Improved Drastically

May 28
Forecast: Analysts Think Harpoon Therapeutics, Inc.'s (NASDAQ:HARP) Business Prospects Have Improved Drastically

Harpoon Therapeutics (NASDAQ:HARP) Will Have To Spend Its Cash Wisely

Mar 11
Harpoon Therapeutics (NASDAQ:HARP) Will Have To Spend Its Cash Wisely

Harpoon Therapeutics appoints Luke Walker as CMO

Oct 04

Harpoon Therapeutics: A Well Undervalued Tri-Specific Oncology Player

Sep 01

Here's Why We're A Bit Worried About Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Situation

Jul 30
Here's Why We're A Bit Worried About Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Situation

Harpoon Therapeutics: A T-Cell Engager Platform And A Negative Enterprise Value Makes It A Candidate For My 'Bio Boom' Portfolio

Jul 07

Is Harpoon Therapeutics (NASDAQ:HARP) In A Good Position To Invest In Growth?

Mar 08
Is Harpoon Therapeutics (NASDAQ:HARP) In A Good Position To Invest In Growth?

We're Keeping An Eye On Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Rate

Nov 30
We're Keeping An Eye On Harpoon Therapeutics' (NASDAQ:HARP) Cash Burn Rate

Harpoon Therapeutics: A First Look

Sep 16

Harpoon shares slide after early-stage prostate cancer study data fails to impress

Jun 04

Hissedar Getirileri

HARPUS BiotechsUS Pazar
7D0.2%-0.4%-1.2%
1Y243.4%20.1%30.6%

Getiri vs. Endüstri: HARP geçen yıl % 20.1 oranında getiri sağlayan US Biotechs sektörünü aştı.

Getiri vs Piyasa: HARP geçen yıl % 30.6 oranında getiri sağlayan US Piyasasını aştı.

Fiyat Oynaklığı

Is HARP's price volatile compared to industry and market?
HARP volatility
HARP Average Weekly Movement32.6%
Biotechs Industry Average Movement9.6%
Market Average Movement6.0%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

İstikrarlı Hisse Senedi Fiyatı: HARP hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: HARP 'nin haftalık oynaklığı geçtiğimiz yıl boyunca 21% dan 33% a yükseldi.

Şirket Hakkında

KurulduÇalışanlarCEOWeb sitesi
201553Julie Eastlandwww.harpoontx.com

Harpoon Therapeutics, Inc. Temel Bilgiler Özeti

Harpoon Therapeutics'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
HARP temel i̇stati̇sti̇kler
Piyasa değeriUS$492.35m
Kazançlar(TTM)-US$30.50m
Gelir(TTM)US$37.34m

13.2x

P/S Oranı

-16.1x

F/K Oranı

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
HARP gelir tablosu (TTM)
GelirUS$37.34m
Gelir MaliyetiUS$58.63m
Brüt Kâr-US$21.29m
Diğer GiderlerUS$9.21m
Kazançlar-US$30.50m

Son Raporlanan Kazançlar

Sep 30, 2023

Sonraki Kazanç Tarihi

n/a

Hisse başına kazanç (EPS)-1.43
Brüt Marj-57.02%
Net Kâr Marjı-81.67%
Borç/Özkaynak Oranı194.4%

HARP uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün